4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-21-055663
General Counsel sold 2,000 shares at an average $35.93 ($71,860)
- General Counsel acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · General Counsel
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-10 | Exercise or conversion : show line 1 in the form | +2,000 | $1.86 | $3,720 | 3,286 | D |
| 2021-09-10 | Sale : show line 2 in the form | −700 | $35.10 | $24,568 | 2,586 | D |
| 2021-09-10 | Sale : show line 3 in the form | −500 | $35.77 | $17,884 | 2,086 | D |
| 2021-09-10 | Sale : show line 4 in the form | −800 | $36.76 | $29,408 | 1,286 | D |
| Open-market sales · 2,000 sh · avg $35.93 · $71,860 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-10 | Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) | −2,000 | 105,666 | D |
Loading xslF345X03/doc4.xml…